China (Mainland)
Cabazitaxel CAS NO.183133-96-2
- Min.Order: 10 Gram
- Payment Terms: L/C,T/T,
- Product Details
Keywords
- Cabazitaxel
- 183133-96-2
- Jevtana
Quick Details
- ProName: Cabazitaxel
- CasNo: 183133-96-2
- Molecular Formula: C45H57NO14
- Appearance: white crystalline powder
- Application: for pharmaceutical usage
- DeliveryTime: 3 days after payment
- PackAge: 25kg/drum
- Port: shanghai,guangzhou,Hong Kong
- ProductionCapacity: 100 Kilogram/Month
- Purity: >99%
- Storage: Kept in a cool, dry and ventilated pla...
- Transportation: by air; by sea
- LimitNum: 10 Gram
- Related Substances: <0.1%
- Residue on Ignition: <0.1%
- Heavy Metal: <0.002%
- Valid Period: 2 years
Superiority
Hengxun pharmaceutical is a leading manufacturer and supplier of chemicals in China. We develop, produce and distribute high quality pharmaceuticals, intermediates, special chemicals and other fine chemicals.
We could give you:
1.Best quality in your requirement
2.Competitive price in China market
3.mature Technical support
4.Professional logistic support
All we want is win-win business. Send yr. inquiries, you will get it!
Details
Cabazitaxel (previously XRP-6258, trade name Jevtana) is a semi-synthetic derivative of a natural taxoid. It was developed by Sanofi-Aventis and was approved by the U.S. Food and Drug Administration (FDA) for the treatment of hormone-refractory prostate cancer on June 17, 2010. It is a microtubule inhibitor, and the fourth taxane to be approved as a cancer therapy.
Cabazitaxel in combination with prednisone is a treatment option for hormone-refractory prostate cancer following docetaxel-based treatment.